TMCNet:  Asia Pacific Cancer Tumors Market Size 2019 Forecasts Report

[September 26, 2013]

Asia Pacific Cancer Tumors Market Size 2019 Forecasts Report

(M2 PressWIRE Via Acquire Media NewsEdge) Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies research report is now available in RnRMarketResearch.com store. This report provides in-depth analysis of four key therapeutic indications within bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these four solid tumor types. The value of the solid tumors market in the APAC region amounted to an estimated $1 billion in 2012 and is expected to register a modest Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in 2019.


The key drivers for growth of Solid Tumors Market in Asia Pacific to 2019 (http://www.rnrmarketresearch.com/solid-tumors-market-in-asia-pacific-to-2019-new-drug-approvals-and-anticipated-product-launches-to-trigger-a-shift-in-treatment-paradigm-to-targeted-therapies-market-report.html ) include: new product approvals in ovarian, pancreatic and prostate cancers; expected launches from the promising ovarian and prostate cancer pipelines; and increased market penetration due to the anticipated implementation of social insurance in China. Conversely, the growth of the market in this region could face some restricting influences, including: the recent implementation of a price ceiling on essential drugs in India; anticipated pricing restrictions in China; low access and penetration; and price erosion due to generic competition.

Scope The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer in the four APAC markets of Australia, China, India and Japan.

The report includes: o Disease overview, as well as treatment algorithms and treatment usage patterns o Market size and forecast for the APAC solid tumors market from 2012 to 2019 o Major marketed products in the APAC region for all four solid tumor types covered o In-depth pipeline analysis for all four solid tumor types o Key drivers and restraints that have had and are expected to have a significant impact upon the market o Key licensing and co-development agreements in the solid tumors market Reasons to Buy (http://www.rnrmarketresearch.com/contacts/purchase?rname=116430 ) : The report will enhance your decision-making capability by allowing you to: o Align your product portfolio to the markets with high growth potential o Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth o Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the solid tumors market o Develop key strategic initiatives based upon an understanding of key focus areas and leading companies o Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships List of Tables provided in the report Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies include: Table 1: Solid Tumors Market, Bladder Cancer, AJCC TNM Staging System, 2010 Table 2: Solid Tumors Market, Bladder Cancer, Treatment by Staging, 2013 Table 3: Solid Tumors Market, Ovarian Cancer, AJCC's TNM and FIGO Staging Systems, 2013 Table 4: Solid Tumors Market, Pancreatic Cancer, AJCC TNM Staging System, 2013 Table 5: Solid Tumors Market, Prostate Cancer, AJCC Staging System, 2013 Table 6: Solid Tumors Market, Global, Pharmaceutical Pipeline (Phase III), 2013 Table 7: Solid Tumors Market, Global, Pharmaceutical Pipeline (Pre-registration/NDA-filed), 2013 Table 8: Solid Tumors Market, Asia-Pacific, Ovarian Cancer, Market Forecast, 2012-2019 Table 9: Solid Tumors Market, Asia-Pacific, Bladder Cancer, Market Forecast, 2012-2019 Table 10: Solid Tumors Market, Asia-Pacific, Pancreatic Cancer, Market Forecast, 2012-2019 Table 11: Solid Tumors Market, Asia-Pacific, Prostate Cancer, Market Forecast, 2012-2019 Table 12: Solid Tumors Market, Australia, Ovarian Cancer, Market Forecast, 2012-2019 Table 13: Solid Tumors Market, Australia, Bladder Cancer, Market Forecast, 2012-2019 Table 14: Solid Tumors Market, Australia, Pancreatic Cancer, Market Forecast, 2012-2019 Table 15: Solid Tumors Market, Australia, Prostate Cancer, Market Forecast, 2012-2019 Table 16: Solid Tumors Market, China, Ovarian Cancer, Market Forecast, 2012-2019 Table 17: Solid Tumors Market, China, Bladder Cancer, Market Forecast, 2012-2019 Table 18: Solid Tumors Market, China, Pancreatic Cancer, Market Forecast, 2012-2019 Table 19: Solid Tumors Market, China, Prostate Cancer, Market Forecast, 2012-2019 Table 20: Solid Tumors Market, India, Ovarian Cancer, Market Forecast, 2012-2019 Table 21: Solid Tumors Market, India, Bladder Cancer, Market Forecast, 2012-2019 Table 22: Solid Tumors Market, India, Pancreatic Cancer, Market Forecast, 2012-2019 Table 23: Solid Tumors Market, India, Prostate Cancer, Market Forecast, 2012-2019 Table 24: Solid Tumors Market, Japan, Ovarian Cancer, Market Forecast, 2012-2019 Table 25: Solid Tumors Market, Japan, Bladder Cancer, Market Forecast, 2012-2019 Table 26: Solid Tumors Market, Japan, Pancreatic Cancer, Market Forecast, 2012-2019 Table 27: Solid Tumors Market, Japan, Prostate Cancer, Market Forecast, 2012-2019 Explore more reports on the Cancer Drugs market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/cancer-drugs .

About Us: RnRMarketResearch.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.

CONTACT: Priyank Tiwari sales@rnrmarketresearch.com +1 888 391 5441 http://www.rnrmarketresearch.com/blog/ ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to info@m2.com)).

(c) 2013 M2 COMMUNICATIONS

[ Back To Cloud Computing 's Homepage ]